Literature DB >> 16984548

Experience and functional outcome of modified ileal neobladder in 95 patients.

Takuya Koie1, Shingo Hatakeyama, Takahiro Yoneyama, Hirofumi Ishimura, Takashi Yamato, Chikara Ohyama.   

Abstract

AIMS: We took advantage of the Goodwin method to develop a modified ileal neobladder. We present the operation procedure and assessed the functional results.
METHODS: From April 1997 and May 2005, 95 patients (75 men and 20 women), mean age 64.6 years (range: 36-80 years) underwent orthotopic ileal neobladder replacement with application of the Goodwin method. The Le Duc technique was used for antireflux procedure. However, for the last 35 patients, antireflux procedure was not carried out. The median follow-up period was 37 months (range: 3-98 months). We reviewed the surgical outcome and complications. Continent status and urodynamic profile were also measured.
RESULTS: The mean operation time for the neobladder formation was 130 mins (range: 65-285 mins). There were no perioperative deaths. Leakage from the ileourethral anastomosis leak was found in four patients (4.2%), wound infection in nine patients (9.5%), ileal anastomosis leak in two patients (2.1%) and paralytic ileus in two patients. No hydronephrosis, neobladder-ureteral reflux or deterioration of renal function was seen. The maximum neobladder pressure was 21 +/- 13 cm (mean +/- SD) at 6 months and 12 +/- 11 cm at 12 months after surgery. The neobladder capacity was 293 +/- 118 mL at 6 months and 312 +/- 85 mL at 12 months after surgery. Of the 95 patients, 87 (91.6%) maintained complete dryness day and night.
CONCLUSIONS: These results suggest that the present orthotopic ileal neobladder is simple to be carried out and achieves acceptable voiding function. Longer observation for neobladder and upper urinary tract function is necessary.

Entities:  

Mesh:

Year:  2006        PMID: 16984548     DOI: 10.1111/j.1442-2042.2006.01525.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  13 in total

1.  Genital nerve stimulation increases bladder capacity after SCI: A meta-analysis.

Authors:  Dennis J Bourbeau; Graham H Creasey; Steven Sidik; Steven W Brose; Kenneth J Gustafson
Journal:  J Spinal Cord Med       Date:  2017-02-15       Impact factor: 1.985

2.  Detecting asymptomatic recurrence after radical cystectomy contributes to better prognosis in patients with muscle-invasive bladder cancer.

Authors:  Ayumu Kusaka; Shingo Hatakeyama; Shogo Hosogoe; Itsuto Hamano; Hiromichi Iwamura; Naoki Fujita; Ken Fukushi; Takuma Narita; Hayato Yamamoto; Yuki Tobisawa; Tohru Yoneyama; Takahiro Yoneyama; Yasuhiro Hashimoto; Takuya Koie; Hiroyuki Ito; Kazuaki Yoshikawa; Toshiaki Kawaguchi; Chikara Ohyama
Journal:  Med Oncol       Date:  2017-04-10       Impact factor: 3.064

3.  Urinary function following radical cystectomy and orthotopic neobladder urinary reconstruction.

Authors:  Ameeta L Nayak; Ilias Cagiannos; Luke T Lavallée; Chris Morash; Duane Hickling; Ranjeeta Mallick; Rodney H Breau
Journal:  Can Urol Assoc J       Date:  2018-02-23       Impact factor: 1.862

4.  Conservative management of a delayed neovesicocutaneous fistula.

Authors:  Koichi Kodama; Yasukazu Takase; Isamu Motoi
Journal:  Case Rep Urol       Date:  2014-06-29

5.  Renal Function Outcomes and Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer [corrected].

Authors:  Shingo Hatakeyama; Takuya Koie; Takuma Narita; Shogo Hosogoe; Hayato Yamamoto; Yuki Tobisawa; Tohru Yoneyama; Takahiro Yoneyama; Yasuhiro Hashimoto; Chikara Ohyama
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

6.  Comparison Between Ambulatory and Conventional Urodynamics of the Modified Orthotopic Hautmann Neobladder.

Authors:  Malioris Apostolos; Dimitriadis Georgios; Kampantais Spyridon; Gkotsos Georgios; Vakalopoulos Ioannis; Ioannidis Stavros; Hatzimoutatidis Konstantinos; Hatzichristou Dimitrios
Journal:  Int Neurourol J       Date:  2015-12-28       Impact factor: 2.835

7.  Preoperative chronic kidney disease predicts poor oncological outcomes after radical cystectomy in patients with muscle-invasive bladder cancer.

Authors:  Itsuto Hamano; Shingo Hatakeyama; Hiromichi Iwamurau; Naoki Fujita; Ken Fukushi; Takuma Narita; Kazuhisa Hagiwara; Ayumu Kusaka; Shogo Hosogoe; Hayato Yamamoto; Yuki Tobisawa; Tohru Yoneyama; Takahiro Yoneyama; Yasuhiro Hashimoto; Takuya Koie; Hiroyuki Ito; Kazuaki Yoshikawa; Toshiaki Kawaguchi; Chikara Ohyama
Journal:  Oncotarget       Date:  2017-05-29

8.  Risk-stratified surveillance and cost effectiveness of follow-up after radical cystectomy in patients with muscle-invasive bladder cancer.

Authors:  Ayumu Kusaka; Shingo Hatakeyama; Shogo Hosogoe; Itsuto Hamano; Hiromichi Iwamura; Naoki Fujita; Ken Fukushi; Takuma Narita; Kazuhisa Hagiwara; Hayato Yamamoto; Yuki Tobisawa; Tohru Yoneyama; Takahiro Yoneyama; Yasuhiro Hashimoto; Takuya Koie; Hiroyuki Ito; Kazuaki Yoshikawa; Toshiaki Kawaguchi; Chikara Ohyama
Journal:  Oncotarget       Date:  2017-07-06

9.  Presence of transient hydronephrosis immediately after surgery has a limited influence on renal function 1 year after ileal neobladder construction.

Authors:  Takuma Narita; Shingo Hatakeyama; Takuya Koie; Shogo Hosogoe; Teppei Matsumoto; Osamu Soma; Hayato Yamamoto; Tohru Yoneyama; Yuki Tobisawa; Takahiro Yoneyama; Yasuhiro Hashimoto; Chikara Ohyama
Journal:  BMC Urol       Date:  2017-08-31       Impact factor: 2.264

10.  Trends in neoadjuvant chemotherapy use and oncological outcomes for muscle-invasive bladder cancer in Japan: a multicenter study.

Authors:  Go Anan; Shingo Hatakeyama; Naoki Fujita; Hiromichi Iwamura; Toshikazu Tanaka; Hayato Yamamoto; Yuki Tobisawa; Tohru Yoneyama; Takahiro Yoneyama; Yasuhiro Hashimoto; Takuya Koie; Hiroyuki Ito; Kazuaki Yoshikawa; Toshiaki Kawaguchi; Makoto Sato; Chikara Ohyama
Journal:  Oncotarget       Date:  2017-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.